ARTICLE | Editor's Commentary
A tale of three disconnects: BioCentury’s sentiment survey reveals major chasms
Silent leadership, FDA cuts and lack of public trust are cracking biotech’s foundations — Editor’s Commentary
April 30, 2025 11:41 PM UTC
The most immediate message of BioCentury’s risk sentiment survey is the collective shock the first 100 or so days of the Trump administration have brought to biotech. But behind the headlines are also three major disconnects, exposing chasms within and beyond the industry that underlie a broad fear about its future.
Bridging them may not be simple, but will be imperative for not just slowing its decline but setting biotech back to where it should be as a valued contributor to U.S. industry and global healthcare...